The purpose of this study was to test the hypothesis that certain clinical and tumor characteristics of KRAS c.34G>T (p.G12C)‐mutated colorectal carcinomas might differ from those of other KRAS‐mutated tumors and KRAS‐wild‐type tumors. The gene discussed is KRAS; the disease is colorectal carcinoma.